Ledger.Open graph →
SEC Form D · filed April 22, 2022

CytoDyn Inc

Offering
—
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Vancouver, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Karen J. Brunke · Vancouver, WADirectorNitya G. Ray · Vancouver, WAExecAntonio D. Migliarese · Vancouver, WAExecScott A. Kelly · Vancouver, WAExec · DirectorLishomwa C. Ndhlovu · Vancouver, WADirectorTanya D. Urbach · Vancouver, WADirectorJordan G. Naydenov · Vancouver, WADirectorKen M. Manning · Iowa City, IAExecJoseph M. Varnas · San Francisco, CAExec · DirectorRobert L. Clark · Boston, MADirectorChristopher M. Klitgaard · Iowa City, IADirectorBrian M. Gragnolati · Iowa City, IAExecErika M. Crandall · San Francisco, CADirectorDaniel M. Krzmarzick · Iowa City, IADirectorNeil S. Mehta · Orinda, CAExecMark Williams · Mansfield, MADirectorAmanda Drobnis · Mansfield, MAExecJessica Mclear · Mansfield, MADirectorAlan Watson · Mansfield, MAExec · DirectorSusan Mason · Franklin, TNDirectorChristine Campanelli · CHICAGO, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗